Market Research Report
Europe Market Overview for Dental Bone Graft Substitutes and Other Biomaterials 2017 - MedView
|Published by||iData Research Inc.||Product code||454908|
|Published||Content info||245 Pages
Delivery time: 1-2 business days
|Europe Market Overview for Dental Bone Graft Substitutes and Other Biomaterials 2017 - MedView|
|Published: February 1, 2017||Content info: 245 Pages||
The European market for dental biomaterials includes dental bone graft substitutes, dental growth factors and dental barrier membranes. The level of development of the dental implant market within a given country highly dictates the corresponding size and growth of the DBGS market within that region. As the patient demand for dental implant procedures increases, the potential number of cases that require a bone grafting procedure also increases. This in turn generates demand for dental bone graft substitutes, barrier membranes and the dental growth factor product, Emdogain®.
Despite the fact that autograft procedures are becoming less popular, they still account for a considerably large portion of dental bone grafting procedures across Europe. As a result, the dental biomaterial market is significantly underdeveloped in Europe, relative to the U.S. market. A prevailing preference for xenograft materials characterizes the dental bone graft substitute market in Europe and very few regions have demonstrated a shift towards allograft materials. It is expected that stringent regulations and protocols set in place by the European Tissue and Cells Directive (EUTCD) will continue to limit the allograft market and overall dental biomaterial market in the future. Other notable developments in the European dental biomaterial market include strategic partnerships between implant companies and biomaterial companies, increasing penetration of allograft materials and the introduction of innovative products that use new materials and composites of existing products.